GSK Deal History & Licensing Activity

About GSK Licensing & Deal Activity

GSK is a large pharma company based in UK that has been actively engaged in licensing transactions across the biopharma landscape. With 56 deals over the past three years, GSK ranks among the most acquisitive companies tracked by Ambrosia Ventures.

Key therapeutic areas of focus for GSK include Infectious Disease (27 deals and trials), Oncology (22 deals and trials), Option Deals (11 deals and trials), and Mega Deals (4 deals and trials). In terms of modality, GSK has shown particular interest in oligonucleotides, small molecules, other.

Ambrosia Ventures tracks deal terms, pipeline data, patent expirations, and competitive positioning for GSK and 850+ other biopharma companies. Use our deal calculator to benchmark your asset against GSK's historical deal terms, or explore all company profiles to find the best partner match for your pipeline.